bw a522 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies
| Studies (bw a522) | Trials (bw a522) | Recent Studies (post-2010) (bw a522) | Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 9,156 | 187 | 552 |
| Protein | Taxonomy | bw a522 (IC50) | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) |
|---|---|---|---|
| Platelet-activating factor receptor | Homo sapiens (human) | 0.0003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, TR; Jacobson, MA; Knight, DA; Salvatore, CA; Walker, BA; Weir, T; Zhou, D | 1 |
1 other study(ies) available for bw a522 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Adenosine A3 receptor expression and function in eosinophils.
Topics: Adenosine; Animals; Bronchi; Cells, Cultured; Chemotaxis, Leukocyte; Eosinophils; Gene Expression Regulation; Humans; Hypersensitivity, Immediate; Iodobenzenes; Lung; Lung Diseases, Obstructive; Mesoderm; Molecular Sequence Data; Platelet Activating Factor; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; RNA, Messenger; Sheep; Xanthines | 1997 |